Respiratory dysfunction and white cell activation following cardiopulmonary bypass: Comparison of membrane and bubble oxygenators

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 9, 1996, Pages 774-783

  Martin, W ^a   Carter, R ^a   Tweddel, A ^a   Belch, J ^b   El Fiky, M ^a   McQuiston, A M ^a   McLaren, M ^b   Wheatley, D J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Complement activation; Membrane versus bubble oxygenation; Respiratory dysfunction; White cell activation

Indexed keywords

COMPLEMENT COMPONENT C3A; LEUKOCYTE ELASTASE; MALONALDEHYDE; THROMBOXANE B2; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD; BLOOD GAS ANALYSIS; BREATHING DISORDER; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOLOGY; INSTRUMENTATION; METABOLISM; MIDDLE AGED; OXYGENATOR; RANDOMIZED CONTROLLED TRIAL; TIME;

BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; COMPLEMENT C3A; HUMANS; LEUKOCYTE ELASTASE; MALONDIALDEHYDE; MIDDLE AGED; OXYGENATORS; RESPIRATION DISORDERS; THROMBOXANE B2; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 0030347292     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80339-3     Document Type: Article

References (24)

1. Cavarocchi NC, Pluth JR, Schaff HV, Orseulak TA, Homburger HA, Solis E, Kaye MP, Clancy MS, Kolff J, Deeb GM (1986) Complement activation during cardiopulmonary bypass: comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg 9:252-258
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW (1981) Complement activation during cardiopulmonary bypass. New Engl J Med 304:497-503
3. Clowes GH Jr, Hopkins AL, Neville WE (1956) An artificial lung dependent upon diffusion of oxyen and carbon dioxide through plastic membranes, J Thorac Surg 32:630-633
4. Collett B, Alhaq A, Abdullah NB, Korjtsas L, Ware RJ, Dodd NJ, Alimo E, Ponte J, Vergan I (1984) Pathways to complement activation during cardiopulmonary bypass. BMJ 289:1251-1254
5. Colman RW (1990) Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 49:32-34
6. Dancy CM, Townsend ER, Boylett A, Chan SL, Parker-Williams J, Parker DJ (1980) Pulmonary dysfunction associated with cardiopulmonary bypass: a comparison of bubble and membrane oxygenators in children. Circulation 64 [Suppl III]:54-57
7. El-Fiky MM, Taggart DP, Carter R, Stockwell MC, Maule BH, Wheatley DJ (1993) Respiratory dysfunction following cardiopulmonary bypass: verification of a non-invasive technique to measure shunt fraction. Respir Med 87:193-198
8. Enhorning G (1989) Surfactant replacement in adult respiratory distress syndrome. Am Rev Resp Dis 140:281-283
9. Kharazmi A, Andersen LW, Baek L, Valerius NH, Laub M, Rasmussen JP (1989) Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 98:381-385
10. Kirklin JK (1991) Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 51:529-531
11. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845-857
12. Kirklin JW (1990) The science of cardiac surgery. Eur J Cardiothorac Surg 4:63-71
13. Martin W, Spyt T, Thomas I, Davidson JF, Wheatley DJ (1989) Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue. Eur J Nucl Med 15:128-132
14. Reigel W, Spillner G, Schlosser V, Horl WH (1988) Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95:1014-1019
15. Sade RM, Bardes DM, Bearing JP, Campbell LJ, Loadholt CB (1980) A prospective randomised study of membrane versus bubble oxygenators in children. Ann Thorac Surg 29:502-511
16. Salama A, Hugo F, Heinrich D, Hoge R, Muller R, Kiefel V, Mueller-Eckhard T, Bhakoi S (1988) Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Engl J Med 318:408-414
17. Shapira N, Zabatino SM, Ahmed S, Murphy DM, Sullivan D, Lemole GM (1990) Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg 50:268-273
18. Smith EE, Naftel DC, Blackstone EH, Kirklin JW (1985) Microvascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg 40:139-143
19. Taggart DP, El-Fiky M, Carter R, Bowman A, Wheatley DJ (1993) Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg 56:1123-1128
20. Taggart DP, Sundaram S, McCartney C, Bowman A, McIntyre H, Courtney JM, Wheatley DJ (1994) Endotoxaemia, complement, and white blood cell activation in cardiac surgery. A randomized trial of laxatives and pulsatile perfusion. Ann Thorac Surg 57:376-382
21. Tennenberg SD, Clardy CW, Bailey WW, Solomkin JS (1990) Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 50:597-601
22. Van den Dungen JJAM, Karliczek GF, Brenken U, Van der Heide JNH, Wildevuur CRH (1982) Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83:108-116
23. Van Oeveren W, Kazatchkine MD, Descamps-Latcha B, Maillet F, Fischere E, Carpentier A, Wildevuur CRH (1985) Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 89:888-889
24. Videm V, Fosse E, Mollnes TE, Ellingsen O, Pedersen T, Karlsen H (1989) Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro. J Thorac Cardiovasc Surg 97:764-770